IL1B and glomerulonephritis: Administration of solnatide (i.p.)significantly reduced inflammation in an experimental glomerulonephritis model, induced by nephrotoxic serum, as it was associated with the reduction in the release of IL-1β and IL-6 and of the chemokines macrophage chemotactic protein (MCP)-1 and keratinocyte-derived chemokine (KC) (19).